ATE209204T1 - Piperidinderivate. - Google Patents
Piperidinderivate.Info
- Publication number
- ATE209204T1 ATE209204T1 AT96907664T AT96907664T ATE209204T1 AT E209204 T1 ATE209204 T1 AT E209204T1 AT 96907664 T AT96907664 T AT 96907664T AT 96907664 T AT96907664 T AT 96907664T AT E209204 T1 ATE209204 T1 AT E209204T1
- Authority
- AT
- Austria
- Prior art keywords
- piperidine derivatives
- represents hydrogen
- lower alkyl
- antagonism
- vomiting
- Prior art date
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical class C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 150000003053 piperidines Chemical class 0.000 abstract 2
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 102100024304 Protachykinin-1 Human genes 0.000 abstract 1
- 101800003906 Substance P Proteins 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 230000008485 antagonism Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000008673 vomiting Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9315095 | 1995-03-27 | ||
| PCT/JP1996/000796 WO1996030367A1 (fr) | 1995-03-27 | 1996-03-27 | Derives de piperidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE209204T1 true ATE209204T1 (de) | 2001-12-15 |
Family
ID=14074519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96907664T ATE209204T1 (de) | 1995-03-27 | 1996-03-27 | Piperidinderivate. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5886011A (de) |
| EP (1) | EP0826684B1 (de) |
| JP (1) | JP3992733B2 (de) |
| KR (1) | KR19980703354A (de) |
| AT (1) | ATE209204T1 (de) |
| AU (1) | AU696948B2 (de) |
| CA (1) | CA2216701A1 (de) |
| DE (1) | DE69617226T2 (de) |
| WO (1) | WO1996030367A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW426667B (en) * | 1997-11-19 | 2001-03-21 | Pfizer | Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists |
| AR018376A1 (es) * | 1998-05-26 | 2001-11-14 | Novartis Ag | Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento |
| EP1029456B1 (de) * | 1998-09-09 | 2005-11-09 | Kewpie Kabushiki Kaisha | Brechreizunterdrueckende nahrungsmittel |
| WO2000071538A2 (en) * | 1999-05-21 | 2000-11-30 | Pfizer Products Inc. | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| DE60012953T2 (de) * | 1999-10-07 | 2005-08-18 | Hisamitsu Pharmaceutical Co., Inc., Tosu | 3-amino-2-phenylpiperidinderivate als substanz p antagonisten |
| AU753853B2 (en) * | 1999-12-14 | 2002-10-31 | Teikoku Seiyaku Co., Ltd | Drugs for relieving hemicrania |
| US7728155B2 (en) | 2003-10-24 | 2010-06-01 | Wyeth Llc | Dihydrobenzofuranyl alkanamines and methods for using same as cns agents |
| US20070218143A1 (en) * | 2006-03-20 | 2007-09-20 | Chong Mok T M | Topical preparation |
| EP2729147B1 (de) | 2011-07-04 | 2017-09-06 | IRBM - Science Park S.p.A. | Nk-1 rezeptorantagonisten zur behandlung der hornhautrevaskularisierung |
| WO2019162519A1 (en) | 2018-02-26 | 2019-08-29 | Ospedale San Raffaele S.R.L. | Nk-1 antagonists for use in the treatment of ocular pain |
| EP4117673A1 (de) | 2020-03-11 | 2023-01-18 | Ospedale San Raffaele S.r.l. | Behandlung von stammzellenmangel |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5232929A (en) * | 1990-11-28 | 1993-08-03 | Pfizer Inc. | 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use |
| CZ293955B6 (cs) * | 1991-03-26 | 2004-08-18 | Pfizeráinc | Postup přípravy substituovaných piperidinů |
| CA2150123C (en) * | 1992-12-10 | 2004-12-07 | Harry R. Howard | Aminomethylene substituted non-aromatic heterocycles |
| US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
-
1996
- 1996-03-27 JP JP52916796A patent/JP3992733B2/ja not_active Expired - Fee Related
- 1996-03-27 KR KR1019970706759A patent/KR19980703354A/ko not_active Application Discontinuation
- 1996-03-27 US US08/913,824 patent/US5886011A/en not_active Expired - Fee Related
- 1996-03-27 CA CA002216701A patent/CA2216701A1/en not_active Abandoned
- 1996-03-27 EP EP96907664A patent/EP0826684B1/de not_active Expired - Lifetime
- 1996-03-27 AU AU51202/96A patent/AU696948B2/en not_active Ceased
- 1996-03-27 DE DE69617226T patent/DE69617226T2/de not_active Expired - Fee Related
- 1996-03-27 AT AT96907664T patent/ATE209204T1/de not_active IP Right Cessation
- 1996-03-27 WO PCT/JP1996/000796 patent/WO1996030367A1/ja not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP3992733B2 (ja) | 2007-10-17 |
| DE69617226D1 (de) | 2002-01-03 |
| EP0826684A1 (de) | 1998-03-04 |
| EP0826684A4 (de) | 1998-07-08 |
| CA2216701A1 (en) | 1996-10-03 |
| AU5120296A (en) | 1996-10-16 |
| DE69617226T2 (de) | 2002-07-25 |
| EP0826684B1 (de) | 2001-11-21 |
| KR19980703354A (ko) | 1998-10-15 |
| WO1996030367A1 (fr) | 1996-10-03 |
| US5886011A (en) | 1999-03-23 |
| AU696948B2 (en) | 1998-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO953305L (no) | Antranilsyrederivat | |
| CA2124680A1 (en) | Piperazine derivatives as 5-ht1a antagonists | |
| FI943142A (fi) | Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt | |
| AU9281198A (en) | Benzofuran derivatives | |
| ATE144772T1 (de) | Piperazinderivate | |
| DK0695755T3 (da) | Pyrrolocarbazoler | |
| ATE209204T1 (de) | Piperidinderivate. | |
| DK0916651T3 (da) | Phenylalkylcarboxylsyrederivater | |
| DE69621469D1 (de) | Phenylpiperidin-derivate | |
| DE69926776D1 (de) | Quinalozinon-derivate | |
| DE60103732D1 (de) | Pyrimidinderivate mit antitumor-wirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |